Can we select NSCLC patients for immune checkpoint therapy?

Baseline autoimmune disorders in NSCLC

In a SEER database, from

14% to 25%

of NSCLC patients have ≥ 1 autoimmune diseases

Patients’ Characteristics

with autoimmune disease

Most common

Autoimmune diseases

Khan – JAMA Oncol 2016 * Khan – Lung Cancer 2018

In lung cancer patients, AD

not associated higher mortality